Since the establishment of the international business department, our products have gradually entered the international market and achieved good sales performance. The company's international business has always adhered to the concept of "the best reputation, the best service and the best quality". After five years of development, it has established a good reputation among global customers, and has been rated as the "best supplier" by many users. The company's sales volume has increased year by year. In 2010, the company was rated as one of the top five Western patent medicine export enterprises by the medical insurance chamber of Commerce in 2010.
The company's products have been sold to the United States, Japan, India, Pakistan, South Korea, Brazil, Egypt, Jordan, Iran, Indonesia, Syria, Canada, Mexico, Taiwan, Hong Kong and other countries and regions.
In the process of internationalization of the company, we attach great importance to the internationalization of the quality system, and require ourselves to meet the requirements of ICH and cGMP standards. At present, the cGMP system of the company has been gradually integrated with Europe and the United States, and has passed the official on-site inspection of Colombia, Japan, Indonesia, Pakistan, Nigeria, South Korea and other countries, and has passed the supplier audit of dozens of world-famous customers.
In terms of international registration, the company has obtained 15 usdmf, 1 jdmf, 3 kdmf, 6 CEP certificates and 17 Indian registration certificates.
The company's main export products are: potassium clavulanate products, isoflurane, sevoflurane, enzophenoic acid, 4-AA, miglitol, isosorbide mononitrate, etc.